Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 20197 | 24.135 |
09:34 ET | 1136 | 24.18 |
09:36 ET | 1097 | 24.095 |
09:38 ET | 1451 | 24.03 |
09:39 ET | 400 | 24.07 |
09:43 ET | 3241 | 24.06 |
09:45 ET | 2197 | 24.03 |
09:48 ET | 100 | 23.98 |
09:50 ET | 2035 | 23.95 |
09:52 ET | 2862 | 24.005 |
09:54 ET | 3072 | 23.92 |
09:56 ET | 10871 | 23.965 |
09:57 ET | 2184 | 23.97 |
09:59 ET | 1189 | 23.955 |
10:01 ET | 2879 | 23.97 |
10:03 ET | 4284 | 24 |
10:06 ET | 2019 | 23.975 |
10:08 ET | 5161 | 23.96 |
10:10 ET | 1300 | 23.98 |
10:12 ET | 1500 | 24.005 |
10:14 ET | 2363 | 24.01 |
10:15 ET | 1208 | 24 |
10:17 ET | 5974 | 24.02 |
10:19 ET | 2256 | 24.04 |
10:21 ET | 1383 | 24.01 |
10:24 ET | 600 | 24.04 |
10:26 ET | 2600 | 24.015 |
10:28 ET | 500 | 23.99 |
10:30 ET | 391 | 24 |
10:32 ET | 1977 | 24.0205 |
10:33 ET | 5067 | 24.01 |
10:35 ET | 2290 | 24.01 |
10:37 ET | 990 | 24.02 |
10:39 ET | 2817 | 24.04 |
10:44 ET | 4800 | 24.01 |
10:46 ET | 1365 | 24.01 |
10:48 ET | 2042 | 24.03 |
10:50 ET | 3864 | 24.06 |
10:51 ET | 1433 | 24.035 |
10:53 ET | 1200 | 24.02 |
10:55 ET | 790 | 24.025 |
10:57 ET | 1490 | 24.015 |
11:00 ET | 5793 | 23.975 |
11:02 ET | 1892 | 23.98 |
11:04 ET | 500 | 23.98 |
11:06 ET | 1450 | 23.98 |
11:08 ET | 5542 | 23.93 |
11:09 ET | 967 | 23.91 |
11:11 ET | 3733 | 23.92 |
11:13 ET | 41832 | 23.935 |
11:15 ET | 3664 | 23.94 |
11:18 ET | 11937 | 23.895 |
11:20 ET | 3599 | 23.88 |
11:22 ET | 10723 | 23.855 |
11:24 ET | 2087 | 23.9 |
11:26 ET | 10141 | 24.02 |
11:27 ET | 3105 | 24 |
11:29 ET | 3838 | 24 |
11:31 ET | 4301 | 24.025 |
11:33 ET | 3133 | 24.04 |
11:36 ET | 4742 | 24.09 |
11:38 ET | 9089 | 24.088 |
11:40 ET | 700 | 24.07 |
11:42 ET | 1100 | 24.02 |
11:44 ET | 1400 | 24.01 |
11:45 ET | 2700 | 24.01 |
11:47 ET | 100 | 24.005 |
11:49 ET | 1335 | 23.96 |
11:51 ET | 1539 | 23.965 |
11:54 ET | 13232 | 23.975 |
11:56 ET | 7352 | 23.985 |
11:58 ET | 3550 | 23.95 |
12:00 ET | 596 | 23.95 |
12:02 ET | 2968 | 23.965 |
12:03 ET | 1602 | 23.965 |
12:05 ET | 2762 | 23.975 |
12:07 ET | 600 | 23.98 |
12:09 ET | 2581 | 23.98 |
12:12 ET | 2506 | 23.97 |
12:14 ET | 721 | 23.97 |
12:16 ET | 1100 | 23.97 |
12:18 ET | 2727 | 23.985 |
12:20 ET | 2138 | 23.99 |
12:21 ET | 634 | 24.005 |
12:23 ET | 2202 | 24.015 |
12:25 ET | 7322 | 24.005 |
12:27 ET | 2057 | 24.01 |
12:30 ET | 847 | 24.02 |
12:32 ET | 2206 | 24.03 |
12:34 ET | 1022 | 24.055 |
12:36 ET | 4400 | 24.02 |
12:38 ET | 233 | 24.02 |
12:39 ET | 700 | 24.01 |
12:41 ET | 450 | 24.015 |
12:43 ET | 2297 | 23.99 |
12:45 ET | 100 | 23.99 |
12:48 ET | 800 | 23.98 |
12:50 ET | 2673 | 23.98 |
12:52 ET | 1807 | 24 |
12:54 ET | 2049 | 24.0069 |
12:56 ET | 252 | 24.0101 |
12:57 ET | 821 | 24.025 |
12:59 ET | 1400 | 24.045 |
01:01 ET | 3470 | 24.045 |
01:03 ET | 400 | 24.05 |
01:06 ET | 6365 | 24.055 |
01:08 ET | 1407 | 24.05 |
01:10 ET | 466 | 24.035 |
01:12 ET | 7525 | 24.03 |
01:14 ET | 300 | 24.03 |
01:15 ET | 1281 | 24.04 |
01:17 ET | 1722 | 24.03 |
01:19 ET | 200 | 24.02 |
01:21 ET | 2798 | 24.05 |
01:24 ET | 1447 | 24.07 |
01:26 ET | 1150 | 24.08 |
01:28 ET | 3360 | 24.03 |
01:30 ET | 7265 | 24 |
01:32 ET | 1613 | 24.02 |
01:33 ET | 1150 | 24.02 |
01:35 ET | 873 | 24.01 |
01:37 ET | 304 | 24 |
01:39 ET | 1000 | 24.01 |
01:42 ET | 13994 | 23.975 |
01:44 ET | 1588 | 23.995 |
01:46 ET | 100 | 23.99 |
01:48 ET | 300 | 23.995 |
01:50 ET | 1449 | 24.005 |
01:51 ET | 4886 | 23.99 |
01:53 ET | 2214 | 24.02 |
01:55 ET | 4529 | 23.99 |
01:57 ET | 200 | 23.99 |
02:00 ET | 1655 | 23.97 |
02:02 ET | 1853 | 23.95 |
02:04 ET | 2121 | 23.97 |
02:06 ET | 3742 | 23.96 |
02:08 ET | 300 | 23.96 |
02:09 ET | 2535 | 23.97 |
02:11 ET | 6344 | 23.94 |
02:13 ET | 3854 | 23.95 |
02:15 ET | 100 | 23.95 |
02:18 ET | 3932 | 23.93 |
02:20 ET | 1739 | 23.93 |
02:22 ET | 4448 | 23.945 |
02:24 ET | 41259 | 23.995 |
02:26 ET | 920 | 24 |
02:27 ET | 2362 | 24.005 |
02:29 ET | 5711 | 24 |
02:31 ET | 8424 | 23.985 |
02:33 ET | 1675 | 23.95 |
02:36 ET | 1761 | 23.94 |
02:38 ET | 2905 | 23.96 |
02:40 ET | 2635 | 23.93 |
02:42 ET | 400 | 23.92 |
02:44 ET | 300 | 23.92 |
02:45 ET | 700 | 23.935 |
02:47 ET | 7001 | 23.91 |
02:49 ET | 1358 | 23.915 |
02:51 ET | 7241 | 23.92 |
02:54 ET | 938 | 23.925 |
02:56 ET | 6520 | 23.95 |
02:58 ET | 5668 | 23.965 |
03:00 ET | 13558 | 24.001 |
03:02 ET | 6746 | 23.975 |
03:03 ET | 2200 | 23.98 |
03:05 ET | 3215 | 24 |
03:07 ET | 3076 | 23.9815 |
03:09 ET | 900 | 23.98 |
03:12 ET | 354 | 23.98 |
03:14 ET | 7204 | 23.97 |
03:16 ET | 4097 | 23.985 |
03:18 ET | 2475 | 23.98 |
03:20 ET | 2231 | 23.9701 |
03:21 ET | 400 | 23.975 |
03:23 ET | 200 | 23.97 |
03:25 ET | 11380 | 23.96 |
03:27 ET | 3396 | 23.969 |
03:30 ET | 7642 | 23.975 |
03:32 ET | 6455 | 23.985 |
03:34 ET | 2616 | 24.005 |
03:36 ET | 5956 | 24.005 |
03:38 ET | 430 | 24 |
03:39 ET | 3219 | 24.015 |
03:41 ET | 16965 | 23.98 |
03:43 ET | 1000 | 23.985 |
03:45 ET | 3832 | 23.995 |
03:48 ET | 14086 | 23.995 |
03:50 ET | 1570 | 23.995 |
03:52 ET | 15400 | 24.005 |
03:54 ET | 15337 | 23.98 |
03:56 ET | 16955 | 23.94 |
03:57 ET | 29520 | 23.93 |
03:59 ET | 84788 | 23.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.0B | 6.8x | --- |
Exelixis Inc | 6.3B | 33.8x | -21.77% |
PTC Therapeutics Inc | 2.9B | -4.8x | --- |
Novavax Inc | 2.5B | -5.7x | --- |
P3 Health Partners Inc | 164.4M | -1.0x | --- |
Halozyme Therapeutics Inc | 5.6B | 21.0x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.43 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.8x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.